{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:03:51Z","timestamp":1790265831146,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Research Council of Norway to NORMENT CoE","award":["#223273"],"award-info":[{"award-number":["#223273"]}]},{"name":"South-Eastern Regional Health Authority","award":["# 2012-100"],"award-info":[{"award-number":["# 2012-100"]}]},{"name":"South-Eastern Regional Health Authority","award":["2017-097"],"award-info":[{"award-number":["2017-097"]}]},{"DOI":"10.13039\/100007793","name":"Stiftelsen Kristian Gerhard Jebsen","doi-asserted-by":"publisher","award":["SKGJ-MED-008"],"award-info":[{"award-number":["SKGJ-MED-008"]}],"id":[{"id":"10.13039\/100007793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research: Neuroimaging"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.pscychresns.2018.10.001","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T07:27:20Z","timestamp":1540798040000},"page":"55-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Association between olanzapine treatment and brain cortical thickness and gray\/white matter contrast is moderated by cholesterol in psychotic disorders"],"prefix":"10.1016","volume":"282","author":[{"given":"Priyanthi B.","family":"Gjerde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5751-4809","authenticated-orcid":false,"given":"Kjetil N.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils E.","family":"Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9783-548X","authenticated-orcid":false,"given":"Ingrid","family":"Melle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole A.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidar M.","family":"Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Agartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pscychresns.2018.10.001_bib0001","first-page":"215","article-title":"The distribution of body mass index among individuals with and without schizophrenia","volume":"60","author":"Allison","year":"1999","journal-title":"J. Clin."},{"issue":"8","key":"10.1016\/j.pscychresns.2018.10.001_bib0002","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jash.2014.04.002","article-title":"The impact of hypertension on cerebral perfusion and cortical thickness in older adults","volume":"8","author":"Alosco","year":"2014","journal-title":"J. Am. Soc. Hypertens."},{"issue":"2","key":"10.1016\/j.pscychresns.2018.10.001_bib0003","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ajhg.2013.01.001","article-title":"Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors","volume":"92","author":"Andreassen","year":"2013","journal-title":"Am. J. Hum. Genet."},{"issue":"7","key":"10.1016\/j.pscychresns.2018.10.001_bib0004","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.neuropharm.2012.01.015","article-title":"Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments","volume":"62","author":"Bartzokis","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pscychresns.2018.10.001_bib0005","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.2741\/3881","article-title":"Neuroglialpharmacology: white matter pathophysiologies and psychiatric treatments","volume":"16","author":"Bartzokis","year":"2011","journal-title":"Front. Biosci. (Landmark Ed.)"},{"issue":"1-3","key":"10.1016\/j.pscychresns.2018.10.001_bib0006","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.schres.2007.02.011","article-title":"Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia","volume":"93","author":"Bartzokis","year":"2007","journal-title":"Schizophr. Res."},{"issue":"1-3","key":"10.1016\/j.pscychresns.2018.10.001_bib0007","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.schres.2012.06.036","article-title":"Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia","volume":"140","author":"Bartzokis","year":"2012","journal-title":"Schizophr. Res."},{"issue":"2-3","key":"10.1016\/j.pscychresns.2018.10.001_bib0008","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.schres.2009.06.014","article-title":"In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia","volume":"113","author":"Bartzokis","year":"2009","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.pscychresns.2018.10.001_bib0009","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1176\/appi.ajp.162.6.1229-a","article-title":"Reduced intracortical myelination in schizophrenia","volume":"162","author":"Bartzokis","year":"2005","journal-title":"Am. J. Psychiatry."},{"issue":"1","key":"10.1016\/j.pscychresns.2018.10.001_bib0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000081413","article-title":"Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample","volume":"11","author":"Berman","year":"2005","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.pscychresns.2018.10.001_bib0003a","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/cne.901180202","article-title":"A note on myeloarchitectonics","volume":"118","author":"Braitenberg","year":"1962","journal-title":"J. Comp. Neurol."},{"issue":"1-2","key":"10.1016\/j.pscychresns.2018.10.001_bib0011","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.psychres.2012.10.010","article-title":"Social dysfunction in first-episode psychosis and relations to neurocognition, duration of untreated psychosis and clinical symptoms","volume":"207","author":"Bratlien","year":"2013","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.pscychresns.2018.10.001_bib0012","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1194\/jlr.R009761","article-title":"Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models","volume":"52","author":"Chrast","year":"2011","journal-title":"J. Lipid Res."},{"issue":"7","key":"10.1016\/j.pscychresns.2018.10.001_bib0013","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1017\/S003329171000200X","article-title":"Global and regional cortical thinning in first-episode psychosis patients: relationships with clinical and cognitive features","volume":"41","author":"Crespo-Facorro","year":"2011","journal-title":"Psychol. Med."},{"issue":"5","key":"10.1016\/j.pscychresns.2018.10.001_bib0014","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/archpsyc.60.5.443","article-title":"White matter changes in schizophrenia: evidence for myelin-related dysfunction","volume":"60","author":"Davis","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pscychresns.2018.10.001_bib0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1745-0179-2-14","article-title":"Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study","volume":"2","author":"De Hert","year":"2006","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"issue":"3","key":"10.1016\/j.pscychresns.2018.10.001_bib0016","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","article-title":"An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest","volume":"31","author":"Desikan","year":"2006","journal-title":"Neuroimage"},{"issue":"5","key":"10.1016\/j.pscychresns.2018.10.001_bib0017","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrn3012","article-title":"Linking lipids to Alzheimer's disease: cholesterol and beyond","volume":"12","author":"Di Paolo","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.pscychresns.2018.10.001_bib0018","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041433-200104000-00003","article-title":"Cholesterol metabolism in the brain","volume":"12","author":"Dietschy","year":"2001","journal-title":"Curr. Opin. Lipidol."},{"issue":"2","key":"10.1016\/j.pscychresns.2018.10.001_bib0019","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1503\/jpn.150030","article-title":"Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2\/3 receptor blockade","volume":"41","author":"Ebdrup","year":"2016","journal-title":"J. Psychiatry Neurosci."},{"issue":"4","key":"10.1016\/j.pscychresns.2018.10.001_bib0020","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/schbul\/sbn193","article-title":"Delusions are associated with poor cognitive insight in schizophrenia","volume":"36","author":"Engh","year":"2010","journal-title":"Schizophr. Bull."},{"issue":"11","key":"10.1016\/j.pscychresns.2018.10.001_bib0021","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/s41398-017-0008-3","article-title":"Subchronic olanzapine exposure leads to increased expression of myelination-related genes in rat fronto-medial cortex","volume":"7","author":"Ersland","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.pscychresns.2018.10.001_bib0022","first-page":"201","article-title":"Differences in the Abeta40\/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein","volume":"48","author":"Fagan","year":"2000","journal-title":"E genotype"},{"issue":"5","key":"10.1016\/j.pscychresns.2018.10.001_bib0023","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.tpj.6500323","article-title":"Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?","volume":"5","author":"Fern\u00f8","year":"2005","journal-title":"Pharmacogenomics J."},{"issue":"1","key":"10.1016\/j.pscychresns.2018.10.001_bib0024","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-2202-7-69","article-title":"Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs","volume":"7","author":"Fern\u00f8","year":"2006","journal-title":"BMC Neurosci."},{"issue":"1","key":"10.1016\/j.pscychresns.2018.10.001_bib0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00213-008-1370-x","article-title":"Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver","volume":"203","author":"Fern\u00f8","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"issue":"1-2","key":"10.1016\/j.pscychresns.2018.10.001_bib0026","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jns.2011.09.004","article-title":"Peroxidation of lipoproteins in multiple sclerosis","volume":"311","author":"Ferretti","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pscychresns.2018.10.001_bib0027","article-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders","author":"First","year":"1996"},{"issue":"2","key":"10.1016\/j.pscychresns.2018.10.001_bib0028","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","article-title":"FreeSurfer","volume":"62","author":"Fischl","year":"2012","journal-title":"Neuroimage"},{"issue":"5","key":"10.1016\/j.pscychresns.2018.10.001_bib0029","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1017\/S1461145712001241","article-title":"Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial","volume":"16","author":"Fleischhacker","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pscychresns.2018.10.001_bib0030","article-title":"Increase in serum HDL level is associated with less negative symptoms after one year of antipsychotic treatment in first-episode psychosis","author":"Gjerde","year":"2017","journal-title":"Schizophr. Res."},{"issue":"Pt 2","key":"10.1016\/j.pscychresns.2018.10.001_bib0031","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neuroimage.2013.03.060","article-title":"Trends and properties of human cerebral cortex: correlations with cortical myelin content","volume":"93","author":"Glasser","year":"2014","journal-title":"Neuroimage"},{"issue":"32","key":"10.1016\/j.pscychresns.2018.10.001_bib0032","doi-asserted-by":"crossref","first-page":"11597","DOI":"10.1523\/JNEUROSCI.2180-11.2011","article-title":"Mapping human cortical areas in vivo based on myelin content as revealed by T1- and T2-weighted MRI","volume":"31","author":"Glasser","year":"2011","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.pscychresns.2018.10.001_bib0033","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/schbul\/sbs118","article-title":"Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects","volume":"39","author":"Haijma","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.pscychresns.2018.10.001_bib0034","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archgenpsychiatry.2010.199","article-title":"Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia","volume":"68","author":"Ho","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.pscychresns.2018.10.001_bib0103","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2574","article-title":"Long-term antipsychotic use and brain changes in schizophrenia - a systematic review and meta-analysis","volume":"32","author":"Huhtaniska","year":"2017","journal-title":"Hum. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.pscychresns.2018.10.001_bib0036","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/schbul\/sbp151","article-title":"Cortical thickness reduction in individuals at ultra-high-risk for psychosis","volume":"37","author":"Jung","year":"2011","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.pscychresns.2018.10.001_bib0037","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/acps.12677","article-title":"Brain volume change in first-episode psychosis: an effect of antipsychotic medication independent of BMI change","volume":"135","author":"J\u00f8rgensen","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"issue":"9","key":"10.1016\/j.pscychresns.2018.10.001_bib0038","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1017\/S0033291716000593","article-title":"Increased MRI-based cortical grey\/white-matter contrast in sensory and motor regions in schizophrenia and bipolar disorder","volume":"46","author":"J\u00f8rgensen","year":"2016","journal-title":"Psychol. Med."},{"issue":"3","key":"10.1016\/j.pscychresns.2018.10.001_bib0039","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.psychres.2012.02.019","article-title":"Impaired plasmalogens in patients with schizophrenia","volume":"198","author":"Kaddurah-Daouk","year":"2012","journal-title":"Psychiatry Res."},{"issue":"&","key":"10.1016\/j.pscychresns.2018.10.001_bib0040","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1093\/schbul\/sbv060","article-title":"Disintegration of Sensorimotor Brain Networks in Schizophrenia","volume":"41","author":"Kaufmann","year":"2015","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.pscychresns.2018.10.001_bib0041","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pscychresns.2018.10.001_bib0108","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/mrm.1910200210","article-title":"Cholesterol of myelin is the determinant of gray-white contrast in MRI of brain","volume":"20","author":"Koenig","year":"1991","journal-title":"Magn. Reson. Med."},{"issue":"5","key":"10.1016\/j.pscychresns.2018.10.001_bib0042","doi-asserted-by":"crossref","first-page":"e37016","DOI":"10.1371\/journal.pone.0037016","article-title":"Reduced gray to white matter tissue intensity contrast in schizophrenia","volume":"7","author":"Kong","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.pscychresns.2018.10.001_bib0043","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.pscychresns.2014.12.004","article-title":"Comparison of grey matter volume and thickness for analysing cortical changes in chronic schizophrenia: a matter of surface area, grey\/white matter intensity contrast, and curvature","volume":"231","author":"Kong","year":"2015","journal-title":"Psychiatry Res"},{"issue":"10","key":"10.1016\/j.pscychresns.2018.10.001_bib0044","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1096\/fj.00-0815fje","article-title":"Essential role for cholesterol in synaptic plasticity and neuronal degeneration","volume":"15","author":"Koudinov","year":"2001","journal-title":"FASEB J."},{"issue":"1-2","key":"10.1016\/j.pscychresns.2018.10.001_bib0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jpsychires.2005.05.005","article-title":"A review of diffusion tensor imaging studies in schizophrenia","volume":"41","author":"Kubicki","year":"2007","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.pscychresns.2018.10.001_bib0046","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0269881112472568","article-title":"Increases in triglyceride levels are associated with clinical response to clozapine treatment","volume":"27","author":"Lally","year":"2013","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.pscychresns.2018.10.001_bib0047","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1001\/jamapsychiatry.2014.2178","article-title":"A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia","volume":"72","author":"Lesh","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.pscychresns.2018.10.001_bib0048","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0896-6273(00)00111-2","article-title":"Catching up on schizophrenia: natural history and neurobiology","volume":"28","author":"Lewis","year":"2000","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.pscychresns.2018.10.001_bib0049","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archpsyc.62.4.361","article-title":"Antipsychotic drug effects on brain morphology in first-episode psychosis","volume":"62","author":"Lieberman","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.pscychresns.2018.10.001_bib0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0006-3223(01)01067-8","article-title":"Longitudinal study of brain morphology in first episode schizophrenia","volume":"49","author":"Lieberman","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"Pt 2","key":"10.1016\/j.pscychresns.2018.10.001_bib0051","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neuroimage.2013.06.005","article-title":"Using high-resolution quantitative mapping of R1 as an index of cortical myelination","volume":"93","author":"Lutti","year":"2014","journal-title":"Neuroimage"},{"issue":"5545","key":"10.1016\/j.pscychresns.2018.10.001_bib0052","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","article-title":"CNS synaptogenesis promoted by glia-derived cholesterol","volume":"294","author":"Mauch","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.pscychresns.2018.10.001_bib0101","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0197-4580(99)00103-7","article-title":"Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer\u2019s disease","volume":"21","author":"Merched","year":"2000","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.pscychresns.2018.10.001_bib0053","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.psychres.2016.01.077","article-title":"Metabolic dysregulation in first-episode schizophrenia patients with respect to genetic variation in one-carbon metabolism","volume":"238","author":"Misiak","year":"2016","journal-title":"Psychiatry Res."},{"issue":"1-3","key":"10.1016\/j.pscychresns.2018.10.001_bib0054","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.schres.2015.03.001","article-title":"Brain structure abnormalities in first-episode psychosis patients with persistent apathy","volume":"164","author":"Morch-Johnsen","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pscychresns.2018.10.001_bib0055","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.295.6600.681","article-title":"Is schizophrenia a neurodevelopmental disorder?","author":"Murray","year":"1987","journal-title":"Br. Med. J."},{"issue":"6","key":"10.1016\/j.pscychresns.2018.10.001_bib0056","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/cercor\/bhh172","article-title":"Mapping cortical thickness and gray matter concentration in first episode schizophrenia","volume":"15","author":"Narr","year":"2005","journal-title":"Cereb. Cortex"},{"issue":"Suppl 1","key":"10.1016\/j.pscychresns.2018.10.001_bib0057","first-page":"1","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.pscychresns.2018.10.001_bib0058","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0022-2275(20)39619-X","article-title":"Lipid composition of the normal human brain: gray matter, white matter, and myelin","volume":"6","author":"O'Brien","year":"1965","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.pscychresns.2018.10.001_bib0059","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/292598","article-title":"Cholesterol: its regulation and role in central nervous system disorders","volume":"2012","author":"Orth","year":"2012","journal-title":"Cholesterol"},{"issue":"3","key":"10.1016\/j.pscychresns.2018.10.001_bib0060","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.neuroimage.2012.01.122","article-title":"Genetic and environmental influences of white and gray matter signal contrast: a new phenotype for imaging genetics?","volume":"60","author":"Panizzon","year":"2012","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.pscychresns.2018.10.001_bib0061","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.comppsych.2006.03.008","article-title":"Generalizability studies of the Global Assessment of Functioning-Split version","volume":"48","author":"Pedersen","year":"2007","journal-title":"Compr. Psychiatry"},{"issue":"6","key":"10.1016\/j.pscychresns.2018.10.001_bib0062","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.biopsych.2011.11.026","article-title":"Cortical volume, surface area, and thickness in schizophrenia and bipolar disorder","volume":"71","author":"Rimol","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.pscychresns.2018.10.001_bib0063","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1073\/pnas.76.9.4646","article-title":"Apolipoproteins in human cerebrospinal fluid","volume":"76","author":"Roheim","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pscychresns.2018.10.001_bib0064","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3389\/fnins.2015.00396","article-title":"Assessing intracortical myelin in the living human brain using myelinated cortical thickness","volume":"9","author":"Rowley","year":"2015","journal-title":"Front Neurosci."},{"issue":"3","key":"10.1016\/j.pscychresns.2018.10.001_bib0065","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.neuroimage.2010.10.034","article-title":"Hippocampal degeneration is associated with temporal and limbic gray matter\/white matter tissue contrast in Alzheimer's disease","volume":"54","author":"Salat","year":"2011","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.pscychresns.2018.10.001_bib0066","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neuroimage.2009.06.074","article-title":"Age-associated alterations in cortical gray and white matter signal intensity and gray to white matter contrast","volume":"48","author":"Salat","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.pscychresns.2018.10.001_bib0067","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption\u2013II","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.pscychresns.2018.10.001_bib0068","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.bbalip.2014.12.016","article-title":"Metabolism and functions of lipids in myelin","volume":"1851","author":"Schmitt","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"2-3","key":"10.1016\/j.pscychresns.2018.10.001_bib0069","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.schres.2009.11.001","article-title":"Reduced cortical thickness in first episode schizophrenia","volume":"116","author":"Schultz","year":"2010","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.pscychresns.2018.10.001_bib0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1001\/jamapsychiatry.2013.2974","article-title":"Functional magnetic resonance imaging of impaired sensory prediction in schizophrenia","volume":"71","author":"Shergill","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.pscychresns.2018.10.001_bib0071","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00002826-199903000-00006","article-title":"The impact of clozapine treatment on serum lipids in chronic schizophrenic patients","volume":"22","author":"Spivak","year":"1999","journal-title":"Clin. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.pscychresns.2018.10.001_bib0072","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.euroneuro.2016.07.011","article-title":"Genetic evidence for a role of the SREBP transcription system and lipid biosynthesis in schizophrenia and antipsychotic treatment","volume":"27","author":"Steen","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.pscychresns.2018.10.001_bib0073","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/npp.2013.288","article-title":"White matter changes associated with antipsychotic treatment in first-episode psychosis","volume":"39","author":"Szeszko","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.pscychresns.2018.10.001_bib0074","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4088\/JCP.v65n0415","article-title":"Hyperlipidemia in persons using antipsychotic medication: a general population-based birth cohort study","volume":"65","author":"Saari","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pscychresns.2018.10.001_bib0075","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1192\/bjp.184.47.s76","article-title":"Metabolic disturbance in first-episode schizophrenia","volume":"47","author":"Thakore","year":"2004","journal-title":"Br. J. Psychiatry. Suppl."},{"issue":"26","key":"10.1016\/j.pscychresns.2018.10.001_bib0076","first-page":"1","article-title":"Archival report abnormal trajectory of intracortical myelination in schizophrenia implicates white matter in disease pathophysiology and the therapeutic mechanism of action of antipsychotics","author":"Tishler","year":"2017","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.pscychresns.2018.10.001_bib0077","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/325789","article-title":"Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study","author":"Uranova","year":"2011","journal-title":"Schizophr. Res. Treatment"},{"issue":"5","key":"10.1016\/j.pscychresns.2018.10.001_bib0078","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0361-9230(01)00528-7","article-title":"Electron microscopy of oligodendroglia in severe mental illness","volume":"55","author":"Uranova","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pscychresns.2018.10.001_bib0100","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/ana.10220","article-title":"Association between high-density lipoprotein and cognitive impairment in the oldest old","volume":"51","author":"van Exel","year":"2002","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.pscychresns.2018.10.001_bib0079","doi-asserted-by":"crossref","first-page":"997","DOI":"10.4088\/JCP.08m04508","article-title":"Metabolic risk factors in drug-naive patients with first-episode psychosis","volume":"70","author":"Verma","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"10","key":"10.1016\/j.pscychresns.2018.10.001_bib0080","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1002\/hbm.23267","article-title":"Accelerated longitudinal gray\/white matter contrast decline in aging in lightly myelinated cortical regions","volume":"37","author":"Vidal-Pineiro","year":"2016","journal-title":"Hum. Brain Mapp."},{"issue":"5","key":"10.1016\/j.pscychresns.2018.10.001_bib0081","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1017\/S1461145708008468","article-title":"Increased expression of lipid biosynthesis genes in peripheral blood cells of olanzapine-treated patients","volume":"11","author":"Vik-Mo","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"8","key":"10.1016\/j.pscychresns.2018.10.001_bib0082","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2210-9-10","article-title":"Psychotropic drugs up-regulate the expression of cholesterol transport proteins including ApoE in cultured human CNS- and liver cells","volume":"9","author":"Vik-Mo","year":"2009","journal-title":"BMC Pharmacol"},{"issue":"1-3","key":"10.1016\/j.pscychresns.2018.10.001_bib0083","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.schres.2016.04.023","article-title":"Ultrastructural alterations of oligodendrocytes in prefrontal white matter in schizophrenia: a post-mortem morphometric study","volume":"177","author":"Vikhreva","year":"2016","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.pscychresns.2018.10.001_bib0084","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.biopsych.2015.02.008","article-title":"The effect of antipsychotic treatment on cortical gray matter changes in schizophrenia: does the class matter? A meta-analysis and meta-regression of longitudinal magnetic resonance imaging studies","volume":"78","author":"Vita","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.pscychresns.2018.10.001_bib0085","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.neubiorev.2006.02.001","article-title":"Neuropathological, neurogenetic and neuroimaging evidence for white matter pathology in schizophrenia","volume":"30","author":"Walterfang","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.pscychresns.2018.10.001_bib0086","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0920-9964(95)00013-C","article-title":"Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground","volume":"16","author":"Weinberger","year":"1995","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.pscychresns.2018.10.001_bib0087","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.schres.2013.07.051","article-title":"The comparison of glycometabolism parameters and lipid profiles between drug-naive, first-episode schizophrenia patients and healthy controls","volume":"150","author":"Wu","year":"2013","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.pscychresns.2018.10.001_bib0088","first-page":"8","article-title":"Behavioral and neurobiological changes in C57BL\/6 mouse exposed to cuprizone: effects of antipsychotics","volume":"4","author":"Xu","year":"2010","journal-title":"Front. Behav. Neurosci."},{"issue":"4","key":"10.1016\/j.pscychresns.2018.10.001_bib0089","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/0269881114562090","article-title":"\u201cFirst do no harm.\u201d A systematic review of the prevalence and management of antipsychotic adverse effects","volume":"29","author":"Young","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.pscychresns.2018.10.001_bib0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2016.09.001","article-title":"Cardiometabolic risk in first-episode schizophrenia (FES) patients with the earliest stages of both illness and antipsychotic treatment","volume":"179","author":"Zhai","year":"2017","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.pscychresns.2018.10.001_bib0091","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.schres.2012.04.006","article-title":"Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination","volume":"138","author":"Zhang","year":"2012","journal-title":"Schizophr. Res."}],"container-title":["Psychiatry Research: Neuroimaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925492718301392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925492718301392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T20:32:07Z","timestamp":1662323527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925492718301392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":95,"alternative-id":["S0925492718301392"],"URL":"https:\/\/doi.org\/10.1016\/j.pscychresns.2018.10.001","relation":{},"ISSN":["0925-4927"],"issn-type":[{"value":"0925-4927","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between olanzapine treatment and brain cortical thickness and gray\/white matter contrast is moderated by cholesterol in psychotic disorders","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research: Neuroimaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pscychresns.2018.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}